Altimmune
ALT
#7345
Rank
ยฃ0.43 B
Marketcap
ยฃ2.26
Share price
-0.97%
Change (1 day)
-10.30%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2026 (TTM): -ยฃ67.63 Million

According to Altimmune's latest financial reports the company's current earnings are ยฃ0.03 Million. In 2025 the company made an earning of -ยฃ65.69 Million, an increase over its 2024 earnings that were of -ยฃ70.34 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ67.63 Million2.96%
2025 -ยฃ65.69 Million-6.61%
2024 -ยฃ70.34 Million7.48%
2023 -ยฃ65.45 Million4.17%
2022 -ยฃ62.83 Million-12.55%
2021 -ยฃ71.84 Million78.27%
2020 -ยฃ40.3 Million164.65%
2019 -ยฃ15.23 Million-54.59%
2018 -ยฃ33.54 Million-12.95%
2017 -ยฃ38.53 Million-164.04%
2016 ยฃ60.15 M-2506.1%
2015 -ยฃ2.51 Million-65.85%
2014 -ยฃ7.33 Million-15.12%
2013 -ยฃ8.63 Million146.72%
2012 -ยฃ3.5 Million-16.07%
2011 -ยฃ4.17 Million-76.1%
2010 -ยฃ17.43 Million-8.89%
2009 -ยฃ19.13 Million31.17%
2008 -ยฃ14.59 Million549.91%
2007 -ยฃ2.25 Million7.52%
2006 -ยฃ2.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.17 Billion 151.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.44 Million-80.07%๐Ÿ‡บ๐Ÿ‡ธ USA